Abstract: A pharmaceutical composition for administration to mammals comprising: a weak base compound having a compound pKa below about 7; an acidic buffer with a buffer pKa below 7; and optional pharmaceutically acceptable additives, wherein the composition has a pH below about 4 is provided. Preferred pharmaceutically active compounds are imidazole derivatives, pyridine derivatives, and aniline derivatives. The pharmaceutical compositions have greater water solubility than the weak base.

Abstract: A pharmaceutical composition for administration to mammals comprising: a weak base compound having a compound pKa below about 7; an acidic buffer with a buffer pKa below 7; and optional pharmaceutically acceptable additives, wherein the composition has a pH below about 4 is provided. Preferred pharmaceutically active compounds are imidazole derivatives, pyridine derivatives, and aniline derivatives. The pharmaceutical compositions have greater water solubility than the weak base.

Abstract: A process for the preparation of solid unit dosage forms is disclosed wherein a fine spray of a dilute solution of a pharmaceutically active material is gradually finely sprayed over an extended time period onto fine excipient particles undergoing agitation. Extremely small amounts of the pharmaceutically active material are deposited on the excipient particles, allowing the resulting powder to be formed into solid unit dosage forms, such as tablets, containing 100 mcg or less of the active ingredient per unit, with high content uniformity among the solid unit dosage forms.

Abstract: PGE-type compounds are stabilized in a composition comprising a mixture of triacetin and ethanol. This composition surprisingly and unexpectedly retains virtually all of the stability of triacetin compounds and additionally provides the superior water miscibility of ethanol.

Abstract: A process and apparatus for prilling pharmaceuticals and the like. A mixture supply device provides a melted mixture of a pharmaceutical and a vehicle at a preselected pressure and at a temperature less than the decomposition temperature of the pharmaceutical, such vehicle being solid at normal room temperature. One or more guns receive the melted mixture. A pulse generator provides a train of pulses of preselected frequency and width which through a transducer causes a valve in each gun to periodically open at a frequency and for a duration controlled by the pulse frequency and width. Each gun has a nozzle supplying melted material upon opening of the corresponding valve and from which is ejected a series of spaced droplets of melt mixture at the pulse frequency, which droplets are of size controlled by the pulse width.

Abstract: A stable dosage form of PGE-type compounds is obtained by dissolving these compounds in triacetin.